Specific features of the use of alogliptin in various groups of patients with type 2 diabetes mellitus: additional results of the ENTIRE study

Marina V. Shestakova; Ekaterina A. Shestakova; Vera A. Kachko

doi:10.14341/probl12273-9727

For citations:

Shestakova M.V., Shestakova E.A., Kachko V.A. Specific features of the use of alogliptin in various groups of patients with type 2 diabetes mellitus: additional results of the ENTIRE study. Problems of Endocrinology. 2020;66(2):49-60. (In Russ.) https://doi.org/10.14341/probl12273

Views PDF (Rus): 511

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Problems of Endocrinology

For citations:

Cookies policy